AVALO THERAPEUTICS, INC. Current Portion of Long-Term Debt
AVALO THERAPEUTICS, INC. (AVTX) had Current Portion of Long-Term Debt of $1.05 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LongTermDebtCurrent · last filed 2019-11-14
- 2019-09-30: Long-term Debt, Current Maturities $1.05M.
- 2019-06-30: Long-term Debt, Current Maturities $1.05M.
- 2019-03-31: Long-term Debt, Current Maturities $1.05M.
- 2018-12-31: Long-term Debt, Current Maturities $1.05M.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2019-09-30 | $1.05M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.05M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.05M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.05M 10-Q · filed 2019-11-14 |
| 2018-09-30 | $1.05M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $1.05M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $787.50K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-18 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 |
| 2017-06-30 | $607.60K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $1.49M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.35M 10-K · filed 2018-04-02 |
| 2016-09-30 | $3.19M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $3.39M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $3.30M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $3.21M 10-K · filed 2017-03-14 |
| 2015-09-30 | $3.13M 10-Q · filed 2015-11-13 |
| 2014-12-31 | $1.91M 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |